+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Antimicrobial Therapeutics Market 2020-2024 - Product Image

Global Antimicrobial Therapeutics Market 2020-2024

  • ID: 5025029
  • Report
  • May 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • CSL Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Global Antimicrobial Therapeutics Market 2020-2024

The antimicrobial therapeutics market is poised to grow by $ 42.30 million during 2020-2024 progressing at a CAGR of 6% during the forecast period. The reports on antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the recent drug approvals and robust pipeline, initiatives from government agencies, and rising awareness about microbial diseases. In addition, recent drug approvals and robust pipeline is anticipated to boost the growth of the market as well.

The antimicrobial therapeutics market analysis includes application segment and geographic landscapes.

The antimicrobial therapeutics market is segmented as below:

By Application
  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiparasitic
By Geographic Landscapes
  • North America
  • Europe
  • APAC
  • ROW
This study identifies the increase in R&D of therapeutic vaccines as one of the prime reasons driving the antimicrobial therapeutics market growth during the next few years. Also, increased disease diagnostic modalities, and increasing research on combination therapies will lead to sizable demand in the market.

The antimicrobial therapeutics market covers the following areas:
  • Antimicrobial therapeutics market sizing
  • Antimicrobial therapeutics market forecast
  • Antimicrobial therapeutics market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antimicrobial therapeutics market vendors that include AbbVie Inc., CSL Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi. Also, the antimicrobial therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

This study presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

The market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • CSL Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Application
  • Market segments
  • Comparison by Application
  • Antiviral - Market size and forecast 2019-2024
  • Antibacterial - Market size and forecast 2019-2024
  • Antifungal - Market size and forecast 2019-2024
  • Antiparasitic - Market size and forecast 2019-2024
  • Market opportunity by Application
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver – Demand led growth
  • Volume driver – External factors
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • CSL Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Application - Market share 2019-2024 (%)
22: Comparison by Application
23: Antiviral - Market size and forecast 2019-2024 ($ million)
24: Antiviral - Year-over-year growth 2019-2024 (%)
25: Antibacterial - Market size and forecast 2019-2024 ($ million)
26: Antibacterial - Year-over-year growth 2019-2024 (%)
27: Antifungal - Market size and forecast 2019-2024 ($ million)
28: Antifungal - Year-over-year growth 2019-2024 (%)
29: Antiparasitic - Market size and forecast 2019-2024 ($ million)
30: Antiparasitic - Year-over-year growth 2019-2024 (%)
31: Market opportunity by Application
32: Customer landscape
33: Market share by geography 2019-2024 (%)
34: Geographic comparison
35: North America - Market size and forecast 2019-2024 ($ million)
36: North America - Year-over-year growth 2019-2024 (%)
37: Europe - Market size and forecast 2019-2024 ($ million)
38: Europe - Year-over-year growth 2019-2024 (%)
39: APAC - Market size and forecast 2019-2024 ($ million)
40: APAC - Year-over-year growth 2019-2024 (%)
41: ROW - Market size and forecast 2019-2024 ($ million)
42: ROW - Year-over-year growth 2019-2024 (%)
43: Key leading countries
44: Market opportunity by geography ($ million)
45: Impact of drivers and challenges
46: Vendor landscape
47: Landscape disruption
48: Industry risks
49: Vendors covered
50: Market positioning of vendors
51: AbbVie Inc. - Overview
52: AbbVie Inc. - Business segments
53: AbbVie Inc. - Key offerings
54: AbbVie Inc. - Key customers
55: AbbVie Inc. - Segment focus
56: CSL Ltd. - Overview
57: CSL Ltd. - Business segments
58: CSL Ltd. - Key offerings
59: CSL Ltd. - Key customers
60: CSL Ltd. - Segment focus
61: F. Hoffmann-La Roche Ltd. - Overview
62: F. Hoffmann-La Roche Ltd. - Business segments
63: F. Hoffmann-La Roche Ltd. - Key offerings
64: F. Hoffmann-La Roche Ltd. - Key customers
65: F. Hoffmann-La Roche Ltd. - Segment focus
66: Gilead Sciences Inc. - Overview
67: Gilead Sciences Inc. - Product and service
68: Gilead Sciences Inc. - Key offerings
69: Gilead Sciences Inc. - Key customers
70: Gilead Sciences Inc. - Segment focus
71: GlaxoSmithKline Plc - Overview
72: GlaxoSmithKline Plc - Business segments
73: GlaxoSmithKline Plc - Key offerings
74: GlaxoSmithKline Plc - Key customers
75: GlaxoSmithKline Plc - Segment focus
76: Johnson & Johnson - Overview
77: Johnson & Johnson - Business segments
78: Johnson & Johnson - Key offerings
79: Johnson & Johnson - Key customers
80: Johnson & Johnson - Segment focus
81: Merck & Co. Inc. - Overview
82: Merck & Co. Inc. - Business segments
83: Merck & Co. Inc. - Key offerings
84: Merck & Co. Inc. - Key customers
85: Merck & Co. Inc. - Segment focus
86: Novartis AG - Overview
87: Novartis AG - Business segments
88: Novartis AG - Key offerings
89: Novartis AG - Key customers
90: Novartis AG - Segment focus
91: Pfizer Inc. - Overview
92: Pfizer Inc. - Business segments
93: Pfizer Inc. - Key offerings
94: Pfizer Inc. - Key customers
95: Pfizer Inc. - Segment focus
96: Sanofi - Overview
97: Sanofi - Business segments
98: Sanofi - Key offerings
99: Sanofi - Key customers
100: Sanofi - Segment focus
101: Currency conversion rates for US$
102: Research Methodology
103: Validation techniques employed for market sizing
104: Information sources
105: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • CSL Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • MORE
The publisher recognizes the following companies as the key players in the global antimicrobial therapeutics market: AbbVie Inc., CSL Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in R&D of therapeutic vaccines."

According to the report, one of the major drivers for this market is the recent drug approvals and robust pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • AbbVie Inc.
  • CSL Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll